Research suggests that locally advanced rectal cancer may respond to HER2 therapy, potentially offering a new treatment approach. Some outlets are reporting significant breakthroughs in colorectal cancer treatment, although the specifics and outcomes of these developments are not entirely clear. The field of colorectal cancer research appears to be actively exploring various therapeutic options, including immunotherapy and targeted therapies.